Pregnant clinical trials

Explore recruiting pregnant clinical trials.

Recruiting pregnant studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pregnant trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A follow-up trial to assess the persistence of the immune response to the Group B Streptococcus vaccine (GBS‑NN/NN2) after a primary vaccination of healthy pregnant women, and to assess safety, reactogenicity and immunogenicity of the GBS‑NN/NN2 vaccine when administered during the follow-up as a 1 booster dose during a new pregnancy

Denmark

Phase II and Phase III (Integrated) EU CTIS Study details

The optimal timing of vaccination in pregnancy: a multi-dimensional mechanistic approach to measure immune responses in pregnant women (MATIMMUNE)

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Congenital CMV treated with valaciclovir during pregnancy: a prospective cohort study

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase IV, multicenter, open-label, single-arm, open-label study to evaluate the safety of almagate in pregnant women with acidity and heartburn, and on perinatal outcomes in the fetus and newborn

Spain

Therapeutic use (Phase IV) EU CTIS Study details

C1091009 - A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT GROUP B STREPTOCOCCUS VACCINE IN HEALTHY PREGNANT WOMEN AND THEIR INFANTS

Finland, Netherlands, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Study on Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women (PANNA)

Spain, Ireland, Netherlands, Belgium, Germany

Therapeutic use (Phase IV) EU CTIS Study details

Pregnant trials by city

Pregnant in Toronto Pregnant in Vancouver Pregnant in Montreal Pregnant in Calgary Pregnant in Edmonton Pregnant in Ottawa Pregnant in Winnipeg Pregnant in Quebec City Pregnant in Hamilton Pregnant in Kitchener Pregnant in London Pregnant in Halifax Pregnant in New York Pregnant in Los Angeles Pregnant in Chicago Pregnant in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease